These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 1540961

  • 1. Immunoreactive human chorionic gonadotropin and its free beta subunit in serum and ascites of patients with malignant tumors.
    Hoermann R, Gerbes AL, Spoettl G, Jüngst D, Mann K.
    Cancer Res; 1992 Mar 15; 52(6):1520-4. PubMed ID: 1540961
    [Abstract] [Full Text] [Related]

  • 2. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.
    Marcillac I, Troalen F, Bidart JM, Ghillani P, Ribrag V, Escudier B, Malassagne B, Droz JP, Lhommé C, Rougier P.
    Cancer Res; 1992 Jul 15; 52(14):3901-7. PubMed ID: 1377600
    [Abstract] [Full Text] [Related]

  • 3. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA, Khanlian SA, Muller CY, Giddings A, Kohorn E, Berkowitz R.
    Gynecol Oncol; 2006 Aug 15; 102(2):160-4. PubMed ID: 16631918
    [Abstract] [Full Text] [Related]

  • 4. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA, Wang YX, Elliott M, Latif M, Chambers JT, Chambers SK, Schwartz PE.
    Cancer Res; 1988 Mar 01; 48(5):1356-60. PubMed ID: 3342414
    [Abstract] [Full Text] [Related]

  • 5. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
    O'Connor JF, Schlatterer JP, Birken S, Krichevsky A, Armstrong EG, McMahon D, Canfield RE.
    Cancer Res; 1988 Mar 01; 48(5):1361-6. PubMed ID: 2449279
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin free beta-subunit: tumor markers and tumor promoters.
    Cole LA, Butler SA.
    J Reprod Med; 2008 Jul 01; 53(7):499-512. PubMed ID: 18720925
    [Abstract] [Full Text] [Related]

  • 10. Measurement of human chorionic gonadotropin-related immunoreactivity in serum, ascites and tumour cysts of patients with gynaecologic malignancies.
    Grossmann M, Hoermann R, Gocze PM, Ott M, Berger P, Mann K.
    Eur J Clin Invest; 1995 Nov 01; 25(11):867-73. PubMed ID: 8582453
    [Abstract] [Full Text] [Related]

  • 11. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
    Dirnhofer S, Freund M, Rogatsch H, Krabichler S, Berger P.
    Hum Pathol; 2000 Aug 01; 31(8):966-72. PubMed ID: 10987258
    [Abstract] [Full Text] [Related]

  • 12. Phantom hCG and phantom choriocarcinoma.
    Cole LA.
    Gynecol Oncol; 1998 Nov 01; 71(2):325-9. PubMed ID: 9826481
    [Abstract] [Full Text] [Related]

  • 13. Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease.
    Alfthan H, Haglund C, Roberts P, Stenman UH.
    Cancer Res; 1992 Sep 01; 52(17):4628-33. PubMed ID: 1324787
    [Abstract] [Full Text] [Related]

  • 14. Human chorionic gonadotropin (hCG) and its free subunits in hydrocele fluids and neoplastic tissue of testicular cancer patients: insights into the in vivo hCG-secretion pattern.
    Madersbacher S, Kratzik C, Gerth R, Dirnhofer S, Berger P.
    Cancer Res; 1994 Oct 01; 54(19):5096-100. PubMed ID: 7923124
    [Abstract] [Full Text] [Related]

  • 15. Human chorionic gonadotropin: properties and assay methods.
    Tyrey L.
    Semin Oncol; 1995 Apr 01; 22(2):121-9. PubMed ID: 7740312
    [Abstract] [Full Text] [Related]

  • 16. Expression and secretion of the beta subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro.
    Nishimura R, Koizumi T, Morisue K, Yamanaka N, Lalwani R, Yoshimura M, Nakagawa T, Shii K, Hasegawa K, Baba S.
    Cancer Res; 1995 Apr 01; 55(7):1479-84. PubMed ID: 7882356
    [Abstract] [Full Text] [Related]

  • 17. The incidence and significance of serum hCG and CEA in patients with gastrointestinal malignant tumors.
    Birkenfeld S, Noiman G, Krispin M, Schwartz S, Zakut H.
    Eur J Surg Oncol; 1989 Apr 01; 15(2):103-8. PubMed ID: 2703054
    [Abstract] [Full Text] [Related]

  • 18. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA, Butler S.
    J Reprod Med; 2002 Jun 01; 47(6):433-44. PubMed ID: 12092011
    [Abstract] [Full Text] [Related]

  • 19. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA, Sutton JM.
    J Reprod Med; 2004 Jul 01; 49(7):545-53. PubMed ID: 15305826
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.